Deep Tech is a brand new subscriber-only podcast that brings alive the folks and concepts our editors and reporters are interested by. Episodes are launched each two weeks. We’re making this episode—like a lot of the remainder of our coronavirus protection—free to everybody.
In the case of the newest applied sciences for testing, treating, and stopping the unfold of covid-19, there’s nobody on MIT Know-how Assessment’s employees who’s higher related and higher knowledgeable than Antonio Regalado, the journal’s senior biomedicine editor. Since February, he’s been self-isolating along with his household at their farm home in Maine, whereas persevering with to report on the pandemic. We talked with Antonio about why it’s taking so lengthy to scale up coronavirus testing, what new vaccine applied sciences look most promising, and why he began prepping for the worst method again in January.
Present Notes and Hyperlinks
How to prepare for the coronavirus like a pro, February 28, 2020
The race to find a covid-19 drug in the blood of survivors, April 10, 2020
What is serological testing?, April 15, 2020
How to test everyone for the coronavirus, April 16, 2020
Antonio Regalado: This isn’t the time to rely on a breakthrough. The breakthrough would possibly occur, nevertheless it won’t.
Wade Roush: To get the coronavirus pandemic beneath management, authorities officers say we’ll want brand-new applied sciences for testing that enable us to diagnose extra folks, quicker. However Antonio Regalado, Know-how Assessment’s biomedicine editor, thinks that’s a number of eggs to place in a single basket.
Antonio Regalado: I imply, a breakthrough is one thing that occurs or it would not. I imply, it is arduous to foretell forward of time. What we wish is a expertise the place there is a clear path and it is a matter of doing it and a matter of overcoming obstacles.
Wade Roush: We’ll speak about why the hassle to scale up coronavirus testing goes so slowly right here within the US, and which applied sciences do have the very best likelihood of working—each for diagnostic testing and, ultimately, for making a vaccine in opposition to the virus. I’m Wade Roush, and that is Deep Tech.
[Deep Tech theme]
Wade Roush: Lately the top of the White Home Coronavirus Process Pressure, Deborah Birx, went on Meet the Press and informed NBC’s Chuck Todd that one key to ending the coronavirus lockdown and letting states restart their economies will likely be creating a brand new approach to check whether or not individuals are contaminated.
Deborah Birx: We’ve got to have a breakthrough innovation in testing. We’ve got to have the ability to detect antigen, reasonably than always attempting to detect the precise reside virus or viral particles itself, and to actually transfer into antigen testing. And I do know companies in diagnostics are engaged on that now. We’ve got to have a breakthrough. This RNA testing will carry us actually by means of the spring and summer time, however we have to have an enormous expertise breakthrough and we’re engaged on that on the identical time.
Wade Roush: Right here at Know-how Assessment, we’re all about protecting breakthroughs. Which is why we all know you’ll be able to’t simply snap your fingers and make one occur. Antonio Regalado covers the newest advances in biomedical analysis, and he’s been reporting for months on all points of the coronavirus response, from testing to antiviral medication to novel kinds of vaccines. So I knew he’d have some ideas about Dr. Birx’s pronouncement—and that he’d be capable to inform us how shut we actually are to having a easy at-home antigen check that would substitute for the gradual and complex genetic testing that’s at present our most important approach to verify for the virus.
I reached Antonio at his farm home in Maine. However earlier than we even talked in regards to the science, I wished to know why he began preparing for a disaster method again in January, earlier than the remainder of us had been even taking note of this new coronavirus.
Wade Roush: It did not actually take you lengthy to begin making ready for the coronavirus pandemic in a method which may have appeared excessive to the remainder of us at the moment. So how and when did you notice that this was going to be in all probability essentially the most dramatic, most impactful pandemic of our lifetimes?
Antonio Regalado: After I first heard in regards to the Wuhan virus, it seemed mainly precisely like SARS. And so simply personally, I mentioned, nicely, you already know, I spent a yr engaged on SARS after which SARS went away. And so my determination early on was that. I used to be going to disregard this virus. And I would go away it to public well being reporters to cowl it.
Antonio Regalado: In order that was early or center of January. By the tip of January, I had spoken to a enterprise capitalist named Robert Nelson. He is a associate at Arch Enterprise Companions, a type of influential biotech investor. And his Twitter feed had turned fairly alarming. Like, he was clearly very alarmed by this virus. So I known as him up and I requested him to inform me, you already know, what was going by means of his head. And he was very, very involved that this was what he known as kind of a world prepare wreck in gradual movement. Inside a few days of chatting with Robert Nelson, I despatched my spouse the next e-mail. and I am going to learn it to you. On January 28, 2020. Antonio Regalado wrote to his spouse beneath the topic line, Pandemic Purchasing Listing, “Please get hold of: three bottles of bleach, a number of milks in field, the European variety you’ll be able to hold at room temperature. Giant luggage of: carrots, onions, potatoes, beans and rice.”
Antonio Regalado: So on January 28, my paranoia was excessive and by then, I used to be attempting to organize by buying the provides that I would want to climate the pandemic. However it wasn’t till a month later that I truly wrote a narrative that we revealed in Know-how Assessment about prepping, simply given that you talked about. It looks as if a loopy, paranoid factor to do when the virus is much away. In truth, my spouse, I’ve her reply. She replied to me, “Actually? Why? Is one coming?,” she mentioned of the pandemic. And I mentioned, again to her, “Effectively, there’s one in China.”
Wade Roush: Yeah. Effectively, on reflection, the concept of laying in weeks’ price of provides, simply in case you were not ready to return to the shop to get groceries, that appears actually sensible. And I am simply interested in whether or not in your thoughts, there’s nonetheless a line between rational prepping and survivalist Montana mountain man prepping. Have you learnt what I am getting at?
Antonio Regalado: I do. I do. Let’s face it, prepping is anti-social. It’s anti-social to amass a bunch of provides to your private use, then lock the doorways of your cabin. I do not actually have a lot perception into the hardcore preppers, you already know, individuals who have weapons and stuff and a bunker underground. I imply, clearly in a sure group of individuals near expertise, after they had been fearful in regards to the virus, after they began prepping, has now change into kind of a badge of honor. And so they make noise of it. I might say in my case as a journalist, it was extra an try and be near the story and be a part of the story. If different individuals are prepping and I’ll write about it, then I wished to prep, too.
Wade Roush: However you are glad to have the additional bottles of bleach and the additional cans of beans.
Antonio Regalado: I’ve 100 kilos of flour. Different folks cannot get flour. And II’m attempting to consider how I can take part, apart from by means of the journalism. Ought to I cease doing journalism and change into a contact tracer? Ought to I give away half my flour to any person else who wants it? These are the questions of the day.
Wade Roush: Let’s discuss subsequent about testing. So we all know that one key to ultimately scaling again self-isolation and quarantining and social distancing will likely be massively increasing the quantity of people that can get examined for the coronavirus as much as the purpose the place ideally you’ll be able to check thousands and thousands of individuals per day. However the dominant expertise that is getting used for that proper now’s one thing known as PCR or RT-PCR. And it is apparently actually troublesome to scale up, as a result of we’re not doing very nicely at it. So might you clarify for us what RT-PCR is, and why the enlargement of that type of testing continues to be taking so lengthy?
Antonio Regalado: Yeah. Effectively, when these testing issues first began to come up and be reported, it was mind-boggling to me, as a result of PCR, polymerase chain response, isn’t a brand new expertise. It was developed within the ’80s. And it is one thing that each single graduate pupil in a biology lab is aware of how you can do. So I used to be type of astonished that there was a dialogue occurring about PCR. You recognize, how is it that individuals have forgotten how to do that bread and butter exercise? And why is it that the power to do that check is in some way contingent on some type of authorities approval or authorities provides? So all that was very unusual to me, as a result of PCR is so elementary to genetic analysis.
Antonio Regalado: What it does is mainly simply amplify DNA. You’ve gotten a little bit little bit of DNA and PCR is what you utilize to multiply it into a number of DNA which you can then simply measure. So it seems, although, that the entire kind of infrastructure for doing PCR testing is extra fragile than we knew, and more durable scale up than we might have thought. And that’s as a result of initially a few of the chemical substances that had been used to type of information the PCR response had been flawed. They did not work appropriately. Then all of a sudden there was a scarcity of these items. They’re known as primers. That was resolved. However then there was a scarcity of one thing that else that you simply wanted, one other chemical to mainly flip the virus’s RNA into DNA. It is known as reverse transcriptase. There was a all of a sudden a scarcity of that.
Antonio Regalado: So you’ll be able to give it some thought as cooking. You recognize, for cooking, you want flour and also you want sugar and also you want a bowl and also you want a mixing spoon and also you want all these items. And so what occurred with the testing is, there was a disaster within the provide of each a kind of issues that occurred at totally different instances. So everyone wished to cook dinner brownies at precisely the identical time. And that was the issue with scaling up. There simply wasn’t sufficient of all these totally different supplies. However the course of itself, apparently, is a little bit bit arduous to scale as much as thousands and thousands or tens of thousands and thousands simply utilizing PCR. So individuals are taking a look at totally different applied sciences that is perhaps extra amenable to kind of massive-scale testing.
Wade Roush: So Deborah Birx, who’s the top of the White Home Coronavirus Process Pressure, has began speaking about antigen testing, which is an strategy that would not depend on PCR, as I perceive it. That is one of many new types of testing that would maybe come to the rescue, however I think about it has its personal scaling points.
Antonio Regalado: Attending to this query of how you can scale up testing in a large method, there’s kind of two common classes of the place new expertise may also help. One is very large centralized testing. And the second is very large decentralized testing. So let me simply discuss in regards to the centralized testing first. Proper now, the PCR testing is centralized. The samples are despatched to medical laboratories, public well being laboratories, business firms like LabCorp or Quest Diagnostics which have facilities, amenities that do the testing. And that accounts for the delay. Like individuals are having lengthy delays in getting their check outcomes, 4 or 5 days.
Antonio Regalado: So there are concepts which are popping out of the genome facilities just like the Broad Institute of MIT and Harvard, out of UCLA, out of Berkeley. And these are schemes for doing huge testing by utilizing the genome sequencing machines which are usually used to sequence human genomes. And so what folks have give you are schemes by which hundreds, tens of hundreds, even thousands and thousands of samples, say, from everywhere in the nation could possibly be pooled collectively after which learn out on these speedy sequencing machines.
Antonio Regalado: In order that’s one thought folks have. However it’s nonetheless, although they imagine that it might get to the size of thousands and thousands, there are a few issues with it. One drawback is simply the logistics, like how do you get all these swabs into one place? And the opposite factor is that it is nonetheless not in actual time. This huge centralized testing, there’s nonetheless delay. You’ve acquired to gather the swabs. You bought to ship them someplace, after which it’s a must to get the outcomes and it’s a must to report the outcomes again. So it is nonetheless a delay.
Antonio Regalado: The opposite class of check, which pertains to Deborah Birx’s remark, is very large decentralized testing. What occurs if there was a check that everyone might use from dwelling earlier than you go to work? After you go to work? As soon as every week, twice every week, you might check your self, and have an thought whether or not you had been contaminated and should you had been, then you might, you’ll know what to do. You’d have to remain dwelling, get in contact with public well being authorities, name your contacts and allow them to know that you’ve this virus. So there’s other ways in idea to do that at dwelling testing.
Deborah Birx is speaking about an antigen check. An antigen check is when you may have an antibody that sticks to the virus. It is in a little bit tiny check package. You are on the lookout for this spike protein on the floor of the virus or possibly another factor that’s truly on the virus poking out of it. The best way I perceive it’s you may have a check strip with antibodies and that that’s going to stay to that antigen whether it is in your nasal swab. However there’s some questions on whether or not an antigen check is definitely going to work. The issue with antigen assessments is that they haven’t labored nicely for respiratory viruses.
Wade Roush: Antonio says that there’s a possible center floor right here. It’s the concept of a simplified genetic check that might mix the accuracy of PCR-based testing with the comfort of decentralized at-home testing.
Antonio Regalado: Who’s engaged on at-home genetic assessments? Effectively, a few of the molecular biologists who had been engaged on the kind of large-scale schemes are additionally engaged on the chemistry for an at dwelling check. Considered one of them is Feng Zhang on the Broad Institute of MIT and Harvard. And he works with this expertise CRISPR, which is understood for gene enhancing. However it seems you’ll be able to adapt it additionally to make a simplified genetic check format. So that they’re attempting to determine, can they make it even less complicated and might they package deal it up in a method that might make it the premise for an at dwelling genetic check?
One other particular person engaged on it’s a well-known entrepreneur named Jonathan Rothberg. He’s fairly a personality. He is in quarantine on his super-yacht, the Gene Machine. However he is additionally somebody with a ton of sources which he has been marshalling to try to create an at-home genetic check. And so they even have prototypes that they are testing at Yale on actual affected person samples. And they’re engaged on creating a little bit system, which might kind of mechanically combine the samples, it’s in regards to the dimension of a bank card. And the concept is that this could be a genetic check that you might do at dwelling. And it seems that the chemistry isn’t essentially the toughest half. There’s all these different sensible parts.
Wade Roush: If we’re gonna have an enormous breakthrough, do you assume it will come from the underside up, or are there any indicators of any kind of top-down management on this?
Antonio Regalado: I don’t know what Deborah Birx meant by a breakthrough, however from what I do know of rising expertise, we should not be relying on breakthroughs, proper? I imply, breakthrough is one thing that occurs or it would not. You recognize, it is arduous to foretell forward of time. What we wish is a expertise the place there is a clear path and it is a matter of doing it, and a matter of overcoming obstacles.
Antonio Regalado: Sri Kosuri is a researcher at UCLA who I spoke with. And he is engaged on a process by which tens of hundreds of affected person samples could possibly be pooled collectively after which run on a sequencing machine. So he got here up with this idea and I simply requested him, nicely, who’s gonna do that? Are you going to do that? Who’s gonna do that? And he mentioned that the issue was that type of everyone is ready for any person else to take the motion. The individuals who can clear up the logistics, they do not essentially imagine that the technologists can do that huge testing, whereas the lecturers, they are not able to do the logistics of accumulating the samples. So there’s this type of sport of a hen and egg is as he described it.
Antonio Regalado: I feel that sure areas like Boston or San Francisco, the place they’ve this focus of educational medical facilities and researchers, they will take the lead. And I feel fairly quickly we’ll see a brand new testing scheme come up in these areas. And as soon as they do this, different folks will observe swimsuit.
Wade Roush: Nice. OK. So, Antonio, let’s end up by speaking in regards to the maybe the largest software of all for ending this pandemic, and that is vaccines. To your thoughts, what are a few of the most attention-grabbing and provocative approaches that individuals are exploring proper now to creating a vaccine in opposition to the coronavirus?
Antonio Regalado: Yeah, nicely, truly, the vaccine efforts acquired underway in a short time, not like the testing. As quickly as that sequence of the coronavirus turned accessible, the folks engaged on vaccines instantly grabbed it and began work. The sequence of the virus is the important start line for the vaccine, and actually, the primary vaccine to succeed in medical trials, I feel they started in late February or early March, is one from a Boston-area biotech known as Moderna Prescription drugs. And so they have a brand new strategy to creating vaccines, through which they mainly take the genetic code, a snippet of the genetic code from the virus, stick it inside a nanoparticle like a little bit ball of fats, they usually inject that into folks. So the objective is that your individual cells will take that data and begin making this little little bit of the virus. Your physique will react to it and you will change into immunized.
Antonio Regalado: And what’s attention-grabbing about Moderna’s strategy is simply the velocity with which they had been in a position to go from the sequence of the virus to their candidate drug or their candidate vaccine. It solely took them a few months. So early on within the pandemic, we already had, you already know, a brand new benchmark that was set for how briskly a vaccine candidate could possibly be ready. In fact, it does not imply theirs will work. In truth, there is not any vaccine of that kind that is broadly used or licensed. So we could find yourself trying as a substitute to extra typical kinds of vaccines, of which there’s numerous methods to make them. And I seemed on the World Well being Group, and I feel that they rely one thing like 50 or so totally different vaccine efforts. So there’s an enormous variety of vaccines in improvement, every utilizing a kind of barely totally different expertise.
Wade Roush: Okay, so one advantage of those new modern approaches, like Moderna’s, is that they is perhaps quicker to implement. However do in addition they have the draw back that they are simply so new that we’re unsure precisely how they will work within the physique but, they usually need to undergo like an equally prolonged testing interval to verify they’re protected?
Antonio Regalado: Right. And this will get again to the purpose of, you already know, ready for a breakthrough. This isn’t the time to rely on a breakthrough. The breakthrough would possibly occur, nevertheless it won’t. So, you already know, at totally different extremes is the Moderna vaccine, which is used as a really intelligent thought. It’s totally quick to get began. However there is not any present vaccine that is broadly used that’s based mostly on this expertise. So it is merely unproven whether or not it makes an efficient vaccine that could possibly be manufactured at massive scale. We simply do not know that. On the different excessive or firms like Johnson & Johnson, Sanofi, and others who’re utilizing what they name vaccine platforms which have a historical past of success. There’s truly vaccines which are on the market which are made utilizing these approaches. They take a little bit bit longer, or quite a bit longer, however they might ultimately be the higher wager. We simply do not know. So I feel lots of people are saying, nicely, we have to wager and wager large on all of the approaches.
Wade Roush: Okay, Antonio, thanks a lot for sharing all this at the moment. And keep protected up there in Maine.
Antonio Regalado: Nice. Thanks, Wade.
Wade Roush: That’s it for this version of Deep Tech.This can be a podcast we’re making completely for MIT Know-how Assessment subscribers, to assist convey alive the concepts our reporters are considering and writing about. However we’re making this episode free for everybody, together with a lot of the remainder of the journal’s coronavirus protection.
Earlier than we go, I need to let you already know a couple of new digital convention arising June eight by means of 10. It’s known as EmTech Subsequent 2020 and it’s a co-production of MIT Know-how Assessment and Harvard Enterprise Assessment. We’ll cowl matters like enterprise agility on this time of unprecedented change. The best way to make companies’ digital operations extra resilient. Advances pushed by new expertise, like machine studying and 5G. And how you can leverage these rising applied sciences to work higher, and smarter. We’ll be joined by visitor audio system resembling Zoom CEO Eric Yuan, Slack co-founder Stewart Butterfield, and Amy Webb, the founder and CEO of the Future At present Institute. Discover out extra and register to your spot at emtechnext.com, that’s E-M-Technext, all one phrase, dot com. We hope to see you in June.
Deep Tech is written and produced by me and edited by Michael Reilly and Jennifer Robust. I’m Wade Roush. Thanks for listening, and we hope to see you again right here for our subsequent episode in two weeks.